David Coelho
About David Coelho
David Coelho is a Senior Scientist at Bristol Myers Squibb with extensive experience in antibody platform technology and therapeutic development projects.
Title and Current Role
David Coelho holds the position of Senior Scientist at Bristol Myers Squibb. He is currently contributing his expertise to the team, furthering his career in the biotechnology and pharmaceutical field.
Previous Positions at Bristol Myers Squibb
Before becoming a Senior Scientist, David Coelho served as a Research Scientist II Antibody Platform Technology at Bristol Myers Squibb from 2019 to 2020. During this time, he focused on antibody platform technology, building on his extensive experience in the field.
Professional Experience at Abbvie Stemcentrx, Inc.
David Coelho worked at Abbvie Stemcentrx, Inc. in various roles. From 2015 to 2019, he was a Scientist I, and later he served as Scientist II in 2019. His work there focused on therapeutic development projects, contributing to advancements in stem cell-based research and therapies.
Educational Background
David Coelho pursued higher education in the sciences, beginning with a Bachelor of Science in Microbiology from Colorado State University, completed in 2001. He furthered his studies at The Pennsylvania State University, earning a Master of Science in Biochemistry and Molecular Biology by 2005. His academic background laid a strong foundation for his research career.
Early Career and Research Roles
In his early career, David Coelho worked at Sirna Therapeutics/Merck & Co., Inc. from 2006 to 2011 as a Staff Biologist, and continued at Merck as a Research Biologist until 2012. During this period, he was involved in RNA interference technology research. He also held research roles at Perseid Therapeutics, AbLexis LLC, and other institutions, gaining wide-ranging experience in molecular biology techniques.